Nitric oxide (Thirty Respiratory)

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameNitric oxide (Thirty Respiratory)
Drug Alias NameRESP-301RESP301
ClassificationSmall molecules
Mechanisms of ActionNitric oxide stimulants
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic ObstructiveBronchiectasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth AfricaUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThirty Respiratory Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThirty Respiratory Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic ObstructiveBronchiectasis +[6] 

Other Information

ATC CodeN/A
Related LinksN/A